APA

Hu R., Dunn T. A., Wei S., Isharwal S., Veltri R. W., Humphreys E., Han M., Partin A. W., Vessella R. L., Isaacs W. B., Bova G. S. & Luo J. (20090130). Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer. : Cancer research.

Chicago

Hu Rong, Dunn Thomas A, Wei Shuanzeng, Isharwal Sumit, Veltri Robert W, Humphreys Elizabeth, Han Misop, Partin Alan W, Vessella Robert L, Isaacs William B, Bova G Steven and Luo Jun. 20090130. Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer. : Cancer research.

Harvard

Hu R., Dunn T. A., Wei S., Isharwal S., Veltri R. W., Humphreys E., Han M., Partin A. W., Vessella R. L., Isaacs W. B., Bova G. S. and Luo J. (20090130). Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer. : Cancer research.

MLA

Hu Rong, Dunn Thomas A, Wei Shuanzeng, Isharwal Sumit, Veltri Robert W, Humphreys Elizabeth, Han Misop, Partin Alan W, Vessella Robert L, Isaacs William B, Bova G Steven and Luo Jun. Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer. : Cancer research. 20090130.